Heron Therapeutics | HRTX - Modal Saham Biasa





Modal Saham Biasa Perubahan Tanggal
ALKERMES USD 168.03M 489K 2026-09
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Amarin USD 20.81M 13K 2025-12
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 141.14M 564K 2026-06
Eisai JPY 282.46M 345K 2026-06
Emergent BioSolutions USD 100K 0 2023-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Heron Therapeutics USD 188.31M 4.99M 2025-12
Insmed USD 218.28M 1.76M 2026-06
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.47B 1.05M 2026-06
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Neurocrine Biosciences USD 101.3M 750K 2026-09
Omeros USD 611K 17K 2023-12
Pacira USD 39.82M 512K 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
Veracyte USD 80.39M 598K 2026-09
Vertex Pharmaceuticals USD 253.5M 200K 2026-09